Mandate

Vinge advises on acquisition of the Frösunda Group

May 03, 2010

Vinge has advised HgCapital in connection with the acquisition of Frösunda LLS AB and its subsidiaries from Polaris Private Equity Fund II and certain minority shareholders. HgCapital’s team was led by Carl Harring.

The transaction is subject to competition law clearance.

The Frösunda Group is the leading private sector personal care provider to people with functional impairments in Sweden with operations in approximately 40 cities and the group has approximately 3700 employees.

Vinge’s team was led by Malin Leffler (responsible partner) and Martin Hall (project manager) and included associates Jonas Bergström, Johan Cederblad, Daniel Unger, Åsa Gotthardsson, Mårten Svensson and Adam Weissbach. Partner Mikael Ståhl was responsible for acquisition financing, assisted by associates Louise Brorsson Salomon and Sofia Graflund. Peter Alstergren provided competition law advice.

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026